Study: Caffeine Impacts Expression of Genes Known to Mediate Cardiovascular Risk

Evidence suggests that caffeine reduces cardiovascular disease risk. However, the mechanism by which this occurs is still unknown. In a new study, researchers from McMaster University and elsewhere investigated the effect of caffeine on the expression of two regulators of circulating low-density lipoprotein (LDL) cholesterol — or ‘bad’ cholesterol — levels.

Caffeine blocks PCSK9 expression and increases LDL cholesterol clearance in hepatocytes. Image credit: Sci-News.com.

Caffeine blocks PCSK9 expression and increases LDL cholesterol clearance in hepatocytes. Image credit: Sci-News.com.

“Just two to three average-sized cups of coffee per day contains enough caffeine to trigger a cascade effect, which reduces the levels of LDL cholesterol,” said McMaster University’s Professor Richard Austin, senior author of the study.

“High bloodstream levels of LDL cholesterol are associated with an increased risk of cardiovascular disease.”

“Regular caffeine consumption is linked to reduced blood levels of the PCSK9 protein, which increases the liver’s ability to remove excess LDL cholesterol from the bloodstream.”

“Coffee and tea drinkers have another important health reason to rejoice — minus the sugar,” he added.

“These findings now provide the underlying mechanism by which caffeine and its derivatives can mitigate the levels of blood PCSK9 and thereby reduce the risk of cardiovascular disease.”

The treatment of liver hepatocytes with caffeine increases the concentration of ER Ca2+: excess ER Ca2+ leads to an increase in the peptide binding capacity and chaperone activity of ER-resident GRP78; the result is an ER-resident GRP78-SREBP2 complex with enhanced stability; the failure of SREBP2 to quickly exit the ER leads to a net reduction in expression of lipid regulatory genes, including PCSK9, SREBP2 and PCSK9; with reduced outflow of de novo PCSK9, cell-surface LDLR exhibits increased half-life and abundance, leading in a net increase in LDL cholesterol clearance. Image credit: Lebeau et al., doi: 10.1038/s41467-022-28240-9.

The treatment of liver hepatocytes with caffeine increases the concentration of ER Ca2+: excess ER Ca2+ leads to an increase in the peptide binding capacity and chaperone activity of ER-resident GRP78; the result is an ER-resident GRP78-SREBP2 complex with enhanced stability; the failure of SREBP2 to quickly exit the ER leads to a net reduction in expression of lipid regulatory genes, including PCSK9, SREBP2 and PCSK9; with reduced outflow of de novo PCSK9, cell-surface LDLR exhibits increased half-life and abundance, leading in a net increase in LDL cholesterol clearance. Image credit: Lebeau et al., doi: 10.1038/s41467-022-28240-9.

Caffeine and its derivatives can also block the activation of a protein called SREBP2, which in turn reduces the levels of PCSK9 into the bloodstream.

“Given that SREBP2 is implicated in a host of cardiometabolic diseases, such as diabetes and fatty liver disease, mitigating its function has far reaching implications,” Professor Austin said.

“Recent population-level studies have shown that coffee and tea drinkers have a reduced risk of death from cardiovascular disease, but a biochemical explanation of this phenomenon has previously eluded researchers,” he added.

“These findings have wide ranging implications as they connect this widely consumed, biologically active compound to cholesterol metabolism at a molecular level,” said McMaster University’s Professor Guillaume Paré, co-author of the study.

“This discovery was completely unexpected and shows that ordinary food and drink have many more complex effects than we think.”

The authors also developed new caffeine derivatives that potently lower blood PCSK9 levels, potentially leading to new LDL cholesterol treatments.

“We are excited to be pursuing this new class of medicines — or nutraceuticals — for the potential treatment and prevention of cardiovascular disease,” said Dr. Jakob Magolan, also from McMaster University.

“It is exciting to see yet another potential clinical benefit from caffeine,” added McMaster University’s Professor Mark Tarnopolsky.

The findings are published in the journal Nature Communications.

_____

P.F. Lebeau et al. 2022. Caffeine blocks SREBP2-induced hepatic PCSK9 expression to enhance LDLR-mediated cholesterol clearance. Nat Commun 13, 770; doi: 10.1038/s41467-022-28240-9

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
What Is the Krebs Cycle? thumbnail

What Is the Krebs Cycle?

You are, right this minute, the site of some unbelievably complicated biochemistry. In order for your body to do literally anything — jump on a trampoline, walk yourself to the bathroom, move your eyeballs as you read this article — you need to be able to accomplish something called cellular respiration, in which your cells…
Read More
XaaS: the exodus of companies to Everything as a Service thumbnail

XaaS: the exodus of companies to Everything as a Service

O XaaS, de Everything of a Service (em português, Tudo como um Serviço) evoluiu a passos largos na última década, com conexões à internet de alta velocidade se tornando mais acessíveis ao grande público. O modelo de negócios diz que qualquer produto em TI, seja um software, um game, bancos de dados, IA, armazenamento, processamento…
Read More
Google and Microsoft Are in a Race to Ruin Search With AI thumbnail

Google and Microsoft Are in a Race to Ruin Search With AI

News Models like ChatGPT are a poor source for any information. @andrew_andrew__ Feb 6, 2023, 4:16 pm EST | 2 min read IgorZh/Shutterstock.com It’s been a rough year for the tech industry—investors are skittish, layoffs are dominating the news, and a pesky tool called ChatGPT threatens to destroy search engines. So, ironically, Google and Microsoft
Read More
A Mission at Home and at Work: Caregivers at Johnson Navigate Dual Role With Community Supports thumbnail

A Mission at Home and at Work: Caregivers at Johnson Navigate Dual Role With Community Supports

Many team members at NASA’s Johnson Space Center in Houston may recognize Alicia Baker as the talented flutist in the Hispanic Employee Resource Group’s Mariachi Celestial band. Or, they may have worked with Baker in her role as a spacesuit project manager, testing NASA’s prototype spacesuits and preparing Johnson’s test chambers to evaluate vendor spacesuits.
Read More
Ako dlho môžu ľudia s covidom zostať nákazliví? Tu sú najlepšie dostupné údaje z krajín thumbnail

Ako dlho môžu ľudia s covidom zostať nákazliví? Tu sú najlepšie dostupné údaje z krajín

Na Slovensku aj v niektorých iných krajín je zavedená už len päťdňová domáca izolácia, týka sa všetkých pozitívne testovaných na covid bez ohľadu na to, či sú zaočkovaní alebo prekonali ochorenie. Infekčná takmer tretina ľudí Niektorí odborníci na choroby v Spojenom kráľovstve aj v USA však varovali, že sa skrátenou izoláciou riskuje, že ľudia neúmyselne rozšíria…
Read More
Climate drove 7,000 years of dietary changes in the Central Andes thumbnail

Climate drove 7,000 years of dietary changes in the Central Andes

What a person eats influences a person's health, longevity and experience in the world. Identifying the factors that determine people's diets is important to answer the bigger questions, such as how changing climates will influence unequal access to preferred foods. A new study led by University of Utah anthropologists provides a blueprint to systematically untangle…
Read More
Index Of News
Total
0
Share